Adult chronic immune thrombocytopenic purpura (chronic ITP) is an autoimmune disorder in which patients produce antiplatelet autoantibodies and specialized white blood cells that destroy their blood platelets and, in some cases, damage their megakaryocytes (the cells that produce platelets in the bone marrow), causing a decrease in platelet production. This results in a low blood platelet count (thrombocytopenia) that may produce bruising or excessive bleeding. The present information has been prepared to help adult patients better understand this condition. However, for specific questions about chronic ITP and recommendations concerning treatment, patients should contact their physicians.
*Please note! All information here is relevant only to adults. The clinical picture and treatment of ITP in children differ and other sources should be sought on this subject, such as the ITP Society of the Children's Blood Foundation.
Standard Treatment of Chronic ITP. Describes the presently accepted forms of therapy used in chronic ITP.
Experimental Treatment of Chronic ITP. Describes experimental treatment approaches applicable to chronic ITP; reviews prelimary results of ongoing studies and provides phone numbers or links to obtain more information about these studies.